Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Assembly Biosciences, Inc. (ASMB)

35.84 -0.29 (-0.80%)
As of 11:13:27 AM EDT. Market Open.
Trade ASMB on Coinbase
Chart Range Bar
Loading chart for ASMB
  • Previous Close 36.13
  • Open 35.68
  • Bid 25.70 x 200
  • Ask 45.69 x 200
  • Day's Range 35.49 - 36.07
  • 52 Week Range 20.23 - 39.71
  • Volume 12,584
  • Avg. Volume 238,936
  • Market Cap (intraday) 729.724M
  • Beta (5Y Monthly) 1.13
  • PE Ratio (TTM) 28.90
  • EPS (TTM) 1.24
  • Earnings Date (est.) --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 52.00

Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide. Its pipeline includes long-acting helicase-primase inhibitors candidates, including ABI-5366 and ABI-1179, which are in Phase 1 clinical studies for recurrent genital herpes; and ABI-6250, an orally bioavailable hepatitis delta virus entry inhibitor that is in Phase 1a clinical study for the treatment of chronic hepatitis delta virus (HDV) infection. The company also develops ABI-4334, an orally bioavailable next generation capsid assembly modulator that is in Phase 1b study clinical trial for the treatment of chronic hepatitis B virus (HBV) infection; and ABI-7272, an oral broad-spectrum NNPI for the treatment of transplant-associated herpesviruses. It has an option, license, and collaboration agreement with Gilead Sciences, Inc. for the research and development of virology therapies. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California.

www.assemblybio.com

73

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Performance Overview

Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

ASMB
5.38%
S&P 500 (^GSPC)
12.62%

1-Year Return

ASMB
53.75%
S&P 500 (^GSPC)
18.57%

3-Year Return

ASMB
204.76%
S&P 500 (^GSPC)
70.72%

5-Year Return

ASMB
8.38%
S&P 500 (^GSPC)
69.98%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 8.21M
Earnings -9.08M
Profit Margin -110.54%

Q2

FY25

Q3

FY25

Q4

FY25

Q1

FY26

-10M
0
10M
20M
30M
40M
-100.0%
-50.0%
0.0%
50.0%

Analyst Insights

View More

Analyst Price Targets

43.00
52.00 Average
35.84 Current
62.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 9/1/2026
Analyst Mizuho
Rating Action Maintains
Rating Outperform
Price Action Lowers
Price Target 53 -> 45

Statistics

View More

Valuation Measures

Annual
As of 9/1/2026
  • Market Cap

    716.29M

  • Enterprise Value

    398.27M

  • Trailing P/E

    28.37

  • Forward P/E

    16.69

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    7.69

  • Price/Book (mrq)

    2.34

  • Enterprise Value/Revenue

    5.32

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -0.06%

  • Return on Assets (ttm)

    -2.67%

  • Return on Equity (ttm)

    -0.03%

  • Revenue (ttm)

    74.84M

  • Net Income Avi to Common (ttm)

    -42k

  • Diluted EPS (ttm)

    1.24

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    320.36M

  • Total Debt/Equity (mrq)

    0.77%

  • Levered Free Cash Flow (ttm)

    -27.87M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

35.84 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports

View More
  • Daily – Vickers Top Buyers & Sellers for 04/16/2025

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • Daily – Vickers Top Buyers & Sellers for 10/10/2024

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • Daily – Vickers Top Buyers & Sellers for 07/09/2024

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • Daily – Vickers Top Buyers & Sellers for 01/22/2024

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: